Cover
Cover - shares | 3 Months Ended | |
Dec. 31, 2022 | Jan. 18, 2023 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Dec. 31, 2022 | |
Document Transition Report | false | |
Entity File Number | 001-33977 | |
Entity Registrant Name | VISA INC. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 26-0267673 | |
Entity Address, Address Line One | P.O. Box 8999 | |
Entity Address, City or Town | San Francisco, | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 94128-8999 | |
City Area Code | 650 | |
Local Phone Number | 432-3200 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Central Index Key | 0001403161 | |
Current Fiscal Year End Date | --09-30 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false | |
Class A common stock | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Class A Common Stock, par value $0.0001 per share | |
Trading Symbol | V | |
Security Exchange Name | NYSE | |
Entity Common Stock, Shares Outstanding | 1,624,954,064 | |
2026 Notes | ||
Document Information [Line Items] | ||
Title of 12(b) Security | 1.500% Senior Notes due 2026 | |
Trading Symbol | V26 | |
Security Exchange Name | NYSE | |
2029 Notes | ||
Document Information [Line Items] | ||
Title of 12(b) Security | 2.000% Senior Notes due 2029 | |
Trading Symbol | V29 | |
Security Exchange Name | NYSE | |
2034 Notes | ||
Document Information [Line Items] | ||
Title of 12(b) Security | 2.375% Senior Notes due 2034 | |
Trading Symbol | V34 | |
Security Exchange Name | NYSE | |
Class B common stock | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 245,513,385 | |
Class C common stock | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 9,745,019 |
CONSOLIDATED BALANCE SHEETS (UN
CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Millions | Dec. 31, 2022 | Sep. 30, 2022 |
Assets | ||
Cash and cash equivalents | $ 13,334 | $ 15,689 |
Restricted cash equivalents—U.S. litigation escrow | 1,705 | 1,449 |
Investment securities | 2,785 | 2,833 |
Settlement receivable | 2,127 | 1,932 |
Accounts receivable | 2,113 | 2,020 |
Customer collateral | 2,591 | 2,342 |
Current portion of client incentives | 1,402 | 1,272 |
Prepaid expenses and other current assets | 1,802 | 2,668 |
Total current assets | 27,859 | 30,205 |
Investment securities | 2,735 | 2,136 |
Client incentives | 3,657 | 3,348 |
Property, equipment and technology, net | 3,236 | 3,223 |
Goodwill | 18,024 | 17,787 |
Intangible assets, net | 26,307 | 25,065 |
Other assets | 3,569 | 3,737 |
Total assets | 85,387 | 85,501 |
Liabilities | ||
Accounts payable | 258 | 340 |
Settlement payable | 3,573 | 3,281 |
Customer collateral | 2,591 | 2,342 |
Accrued compensation and benefits | 736 | 1,359 |
Client incentives | 6,553 | 6,099 |
Accrued liabilities | 3,940 | 3,726 |
Current maturities of debt | 0 | 2,250 |
Accrued litigation | 1,702 | 1,456 |
Total current liabilities | 19,353 | 20,853 |
Long-term debt | 20,487 | 20,200 |
Deferred tax liabilities | 5,443 | 5,332 |
Other liabilities | 3,180 | 3,535 |
Total liabilities | 48,463 | 49,920 |
Equity | ||
Preferred stock | 1,981 | 2,324 |
Common stock and additional paid-in capital | 19,827 | 19,545 |
Right to recover for covered losses | (28) | (35) |
Accumulated income | 16,403 | 16,116 |
Accumulated other comprehensive income (loss), net: | ||
Investment securities | (94) | (106) |
Defined benefit pension and other postretirement plans | (167) | (169) |
Derivative instruments | (213) | 418 |
Foreign currency translation adjustments | (785) | (2,512) |
Total accumulated other comprehensive income (loss), net | (1,259) | (2,369) |
Total equity | 36,924 | 35,581 |
Total liabilities and equity | $ 85,387 | $ 85,501 |
CONSOLIDATED BALANCE SHEETS (_2
CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares shares in Millions | Dec. 31, 2022 | Sep. 30, 2022 |
Preferred Stock | ||
Preferred stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized (in shares) | 25 | 25 |
Preferred stock, shares issued (in shares) | 5 | 5 |
Preferred stock, shares outstanding (in shares) | 5 | 5 |
Series A preferred stock | ||
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Series B preferred stock | ||
Preferred stock, shares issued (in shares) | 2 | 2 |
Preferred stock, shares outstanding (in shares) | 2 | 2 |
Series C preferred stock | ||
Preferred stock, shares issued (in shares) | 3 | 3 |
Preferred stock, shares outstanding (in shares) | 3 | 3 |
Common Stock [Member] | ||
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized (in shares) | 2,003,341 | 2,003,341 |
Common stock, shares issued (in shares) | 1,881 | 1,890 |
Common stock, shares outstanding (in shares) | 1,881 | 1,890 |
Class A common stock | ||
Common stock, shares authorized (in shares) | 2,001,622 | 2,001,622 |
Common stock, shares issued (in shares) | 1,626 | 1,635 |
Common stock, shares outstanding (in shares) | 1,626 | 1,635 |
Class B common stock | ||
Common stock, shares authorized (in shares) | 622 | 622 |
Common stock, shares issued (in shares) | 245 | 245 |
Common stock, shares outstanding (in shares) | 245 | 245 |
Class C common stock | ||
Common stock, shares authorized (in shares) | 1,097 | 1,097 |
Common stock, shares issued (in shares) | 10 | 10 |
Common stock, shares outstanding (in shares) | 10 | 10 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Net revenues | $ 7,936 | $ 7,059 |
Operating Expenses | ||
Personnel | 1,337 | 1,125 |
Marketing | 332 | 280 |
Network and processing | 178 | 190 |
Professional fees | 109 | 100 |
Depreciation and amortization | 227 | 198 |
General and administrative | 322 | 242 |
Litigation provision | 341 | 148 |
Total operating expenses | 2,846 | 2,283 |
Operating income | 5,090 | 4,776 |
Non-operating Income (Expense) | ||
Interest expense | (137) | (134) |
Investment income (expense) and other | 24 | 255 |
Total non-operating income (expense) | (113) | 121 |
Income before income taxes | 4,977 | 4,897 |
Income tax provision | 798 | 938 |
Net income | $ 4,179 | $ 3,959 |
Class A common stock | ||
Earnings Per Share | ||
Basic Earnings Per Share (in dollars per share) | $ 1.99 | $ 1.84 |
Basic Weighted-average Shares Outstanding (in shares) | 1,629 | 1,669 |
Diluted Earnings Per Share (in dollars per share) | $ 1.99 | $ 1.83 |
Diluted Weighted-average Shares Outstanding (in shares) | 2,102 | 2,159 |
Class B common stock | ||
Earnings Per Share | ||
Basic Earnings Per Share (in dollars per share) | $ 3.19 | $ 2.98 |
Basic Weighted-average Shares Outstanding (in shares) | 245 | 245 |
Diluted Earnings Per Share (in dollars per share) | $ 3.19 | $ 2.98 |
Diluted Weighted-average Shares Outstanding (in shares) | 245 | 245 |
Class C common stock | ||
Earnings Per Share | ||
Basic Earnings Per Share (in dollars per share) | $ 7.96 | $ 7.35 |
Basic Weighted-average Shares Outstanding (in shares) | 10 | 10 |
Diluted Earnings Per Share (in dollars per share) | $ 7.95 | $ 7.34 |
Diluted Weighted-average Shares Outstanding (in shares) | 10 | 10 |
CONSOLIDATED STATEMENTS OF COMP
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($) $ in Millions | 3 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Statement of Comprehensive Income [Abstract] | ||
Net income | $ 4,179 | $ 3,959 |
Investment securities: | ||
Net unrealized gain (loss) | 15 | (10) |
Income tax effect | (3) | 2 |
Defined benefit pension and other postretirement plans: | ||
Net unrealized actuarial gain (loss) and prior service credit (cost) | 2 | 1 |
Income tax effect | (1) | 0 |
Reclassification adjustments | 1 | 1 |
Derivative instruments: | ||
Net unrealized gain (loss) | (116) | 114 |
Income tax effect | 14 | (22) |
Reclassification adjustments | (7) | (6) |
Income tax effect | (4) | 0 |
Foreign currency translation adjustments | 1,209 | (588) |
Other comprehensive income (loss), net of tax | 1,110 | (508) |
Comprehensive income | $ 5,289 | $ 3,451 |
CONSOLIDATED STATEMENTS OF CHAN
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) - USD ($) shares in Millions, $ in Millions | Total | Preferred Stock | Common Stock and Additional Paid-in Capital | Right to Recover for Covered Losses | Accumulated Income | Accumulated Other Comprehensive Income (Loss), Net | ||
Beginning balance (in shares) at Sep. 30, 2021 | 5 | |||||||
Beginning balance at Sep. 30, 2021 | $ 37,589 | $ 3,080 | [1] | $ 18,855 | $ (133) | $ 15,351 | $ 436 | |
Beginning balance (in shares) at Sep. 30, 2021 | 1,932 | |||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Net income | 3,959 | 3,959 | ||||||
Other Comprehensive Income (Loss), Net of Tax | (508) | (508) | ||||||
VE territory covered losses incurred | (7) | (7) | ||||||
Recovery through conversion rate adjustment | 0 | $ (29) | 29 | |||||
Conversion to class A common stock upon sales into public market (in shares) | 0 | [2] | 1 | |||||
Conversion to class A common stock upon sales into public market | 0 | $ (56) | $ 56 | |||||
Share-based compensation, net of forfeitures | 128 | $ 128 | ||||||
Stock issued under equity plans (in shares) | 2 | |||||||
Stock issued under equity plans | 59 | $ 59 | ||||||
Restricted stock and performance-based shares settled in cash for taxes (in shares) | [2] | 0 | ||||||
Restricted stock and performance-based shares settled in cash for taxes | (113) | $ (113) | ||||||
Cash dividends declared and paid, at a quarterly amount per class A common stock | (809) | (809) | ||||||
Repurchase of class A common stock (in shares) | (19) | |||||||
Repurchase of class A common stock | (4,104) | $ (209) | (3,895) | |||||
Ending balance (in shares) at Dec. 31, 2021 | 5 | |||||||
Ending balance at Dec. 31, 2021 | 36,194 | $ 2,995 | [1] | $ 18,776 | (111) | 14,606 | (72) | |
Ending balance (in shares) at Dec. 31, 2021 | 1,916 | |||||||
Beginning balance (in shares) at Sep. 30, 2022 | 5 | |||||||
Beginning balance at Sep. 30, 2022 | 35,581 | $ 2,324 | [3] | $ 19,545 | (35) | 16,116 | (2,369) | |
Beginning balance (in shares) at Sep. 30, 2022 | 1,890 | |||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Net income | 4,179 | 4,179 | ||||||
Other Comprehensive Income (Loss), Net of Tax | 1,110 | 1,110 | ||||||
VE territory covered losses incurred | (8) | (8) | ||||||
Recovery through conversion rate adjustment | 1 | $ (14) | 15 | |||||
Conversion to class A common stock upon sales into public market (in shares) | 0 | [4] | 5 | |||||
Conversion to class A common stock upon sales into public market | 0 | $ (329) | $ 329 | |||||
Share-based compensation, net of forfeitures | 177 | $ 177 | ||||||
Stock issued under equity plans (in shares) | 2 | |||||||
Stock issued under equity plans | 56 | $ 56 | ||||||
Restricted stock and performance-based shares settled in cash for taxes (in shares) | [4] | 0 | ||||||
Restricted stock and performance-based shares settled in cash for taxes | (112) | $ (112) | ||||||
Cash dividends declared and paid, at a quarterly amount per class A common stock | (945) | (945) | ||||||
Repurchase of class A common stock (in shares) | (16) | |||||||
Repurchase of class A common stock | (3,115) | $ (168) | (2,947) | |||||
Ending balance (in shares) at Dec. 31, 2022 | 5 | |||||||
Ending balance at Dec. 31, 2022 | $ 36,924 | $ 1,981 | [3] | $ 19,827 | $ (28) | $ 16,403 | $ (1,259) | |
Ending balance (in shares) at Dec. 31, 2022 | 1,881 | |||||||
[1] As of December 31, 2021 and September 30, 2021, the book value of series A preferred stock was $430 million and $486 million, respectively. Refer to Note 4—U.S. and Europe Retrospective Responsibility Plans for the book value of series B and series C preferred stock. As of December 31, 2022 and September 30, 2022, the book value of series A preferred stock was $723 million and $1.0 billion, respectively. Refer to Note 4—U.S. and Europe Retrospective Responsibility Plans for the book value of series B and series C preferred stock. |
CONSOLIDATED STATEMENTS OF CH_2
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) (Parenthetical) - USD ($) $ in Millions | 3 Months Ended | |||
Dec. 31, 2022 | Dec. 31, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Dividends declared, quarterly, per share (in dollars per share) | $ 0.45 | $ 0.375 | ||
Dividends paid, quarterly, per share (in dollars per share) | $ 0.45 | $ 0.375 | ||
Preferred stock | $ 1,981 | $ 2,324 | ||
Series A preferred stock | ||||
Preferred stock | $ 723 | $ 430 | $ 1,000 | $ 486 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions | 3 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Operating Activities | ||
Net income | $ 4,179 | $ 3,959 |
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||
Client incentives | 2,786 | 2,371 |
Share-based compensation | 177 | 128 |
Depreciation and amortization of property, equipment, technology and intangible assets | 227 | 198 |
Deferred income taxes | (132) | (15) |
VE territory covered losses incurred | (8) | (7) |
(Gains) losses on equity investments, net | 106 | (231) |
Other | (26) | (32) |
Change in operating assets and liabilities: | ||
Settlement receivable | (54) | (76) |
Accounts receivable | (60) | (213) |
Client incentives | (2,743) | (2,339) |
Other assets | 160 | (163) |
Accounts payable | (64) | (9) |
Settlement payable | 44 | 409 |
Accrued and other liabilities | (666) | 206 |
Accrued litigation | 245 | 46 |
Net cash provided by (used in) operating activities | 4,171 | 4,232 |
Investing Activities | ||
Purchases of property, equipment and technology | (249) | (173) |
Investment securities: | ||
Purchases | (1,995) | (951) |
Proceeds from maturities and sales | 1,310 | 1,374 |
Acquisitions, net of cash acquired | 0 | (832) |
Purchases of other investments | (20) | (37) |
Settlement of derivative instruments | 402 | 0 |
Other investing activities | 42 | 72 |
Net cash provided by (used in) investing activities | (510) | (547) |
Financing Activities | ||
Repurchase of class A common stock | (3,115) | (4,104) |
Repayments of debt | (2,250) | 0 |
Dividends paid | (945) | (809) |
Cash proceeds from issuance of class A common stock under equity plans | 56 | 59 |
Restricted stock and performance-based shares settled in cash for taxes | (112) | (113) |
Other financing activities | 19 | 0 |
Net cash provided by (used in) financing activities | (6,347) | (4,967) |
Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents | 692 | (194) |
Increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents | (1,994) | (1,476) |
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period | 20,377 | 19,799 |
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period | 18,383 | 18,323 |
Supplemental Disclosure | ||
Cash paid for income taxes, net | 721 | 268 |
Interest payments on debt | 244 | 244 |
Accruals related to purchases of property, equipment and technology | $ 27 | $ 53 |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 3 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Note 1—Summary of Significant Accounting Policies Organization. Visa Inc. and its subsidiaries (Visa or the Company) is a global payments technology company that facilitates global commerce and money movement across more than 200 countries and territories. Visa operates one of the world’s largest electronic payments network — VisaNet — which provides transaction processing services (primarily authorization, clearing and settlement). The Company offers products, solutions and services that facilitate secure, reliable and efficient money movement for participants in the ecosystem. Visa is not a financial institution and does not issue cards, extend credit or set rates and fees for account holders of Visa products. In most cases, account holder and merchant relationships belong to, and are managed by, Visa’s financial institution clients. Consolidation and basis of presentation. The accompanying unaudited consolidated financial statements include the accounts of Visa and its consolidated entities and are presented in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). The Company consolidates its majority-owned and controlled entities, including variable interest entities (VIEs) for which the Company is the primary beneficiary. The Company’s investments in VIEs have not been material to its unaudited consolidated financial statements as of and for the periods presented. All significant intercompany accounts and transactions are eliminated in consolidation. The accompanying unaudited consolidated financial statements are presented in accordance with U.S. Securities and Exchange Commission (SEC) requirements for Quarterly Reports on Form 10-Q and, consequently, do not include all of the annual disclosures required by U.S. GAAP. Reference should be made to the Visa Annual Report on Form 10-K for the year ended September 30, 2022 for additional disclosures, including a summary of the Company’s significant accounting policies. In the opinion of management, the accompanying unaudited consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods presented. The results of operations for interim periods are not necessarily indicative of results for the full year. Use of estimates. The preparation of the accompanying unaudited consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and reported amounts of revenues and expenses during the reporting period. These estimates may change as new events occur and additional information is obtained, and will be recognized in the period in which such changes occur. Future actual results could differ materially from these estimates. |
Revenues
Revenues | 3 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Revenues | Note 2—Revenues The nature, amount, timing and uncertainty of the Company’s revenues and cash flows and how they are affected by economic factors are most appropriately depicted through the Company’s revenue categories and geographical markets. The following tables disaggregate the Company’s net revenues by revenue category and by geography: Three Months Ended 2022 2021 (in millions) Service revenues $ 3,511 $ 3,193 Data processing revenues 3,827 3,614 International transaction revenues 2,797 2,174 Other revenues 587 449 Client incentives (2,786) (2,371) Net revenues $ 7,936 $ 7,059 Three Months Ended 2022 2021 (in millions) U.S. $ 3,567 $ 3,178 International 4,369 3,881 Net revenues $ 7,936 $ 7,059 |
Cash, Cash Equivalents, Restric
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | 3 Months Ended |
Dec. 31, 2022 | |
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] | |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Note 3—Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents The Company reconciles cash, cash equivalents, restricted cash and restricted cash equivalents reported in the consolidated balance sheets that aggregate to the beginning and ending balances shown in the consolidated statements of cash flows as follows: December 31, September 30, (in millions) Cash and cash equivalents $ 13,334 $ 15,689 Restricted cash and restricted cash equivalents: U.S. litigation escrow 1,705 1,449 Customer collateral 2,591 2,342 Prepaid expenses and other current assets 753 897 Cash, cash equivalents, restricted cash and restricted cash equivalents $ 18,383 $ 20,377 |
U.S. and Europe Retrospective R
U.S. and Europe Retrospective Responsibility Plans | 3 Months Ended |
Dec. 31, 2022 | |
Retrospective Responsibility Plans [Abstract] | |
U.S. and Europe Retrospective Responsibility Plans | Note 4—U.S. and Europe Retrospective Responsibility Plans U.S. Retrospective Responsibility Plan Under the terms of the U.S. retrospective responsibility plan, the Company maintains an escrow account from which settlements of, or judgments in, certain litigation referred to as the “U.S. covered litigation” are paid. The accrual related to the U.S. covered litigation could be either higher or lower than the U.S. litigation escrow account balance. See Note 12—Legal Matters . The following table presents the changes in the restricted cash equivalents—U.S. litigation escrow account: Three Months Ended 2022 2021 (in millions) Balance at beginning of period $ 1,449 $ 894 Deposits into the litigation escrow account 350 250 Payments to opt-out merchants (1) , net of interest earned on escrow funds (94) — Balance at end of period $ 1,705 $ 1,144 (1) These payments are associated with the interchange multidistrict litigation. See Note 12—Legal Matters . Europe Retrospective Responsibility Plan Visa Inc., Visa International and Visa Europe are parties to certain existing and potential litigation relating to the setting of multilateral interchange fee rates in the Visa Europe territory (VE territory covered litigation). Under the terms of the Europe retrospective responsibility plan, the Company is entitled to recover certain losses resulting from VE territory covered litigation (VE territory covered losses) through a periodic adjustment to the class A common stock conversion rates applicable to the series B and C preferred stock. VE territory covered losses are recorded in a contra-equity account referred to as “right to recover for covered losses” within stockholders’ equity before the corresponding adjustment to the applicable conversion rate is effected. Adjustments to the conversion rate may be executed once in any six-month period unless a single, individual loss greater than €20 million is incurred, in which case, the six-month limitation does not apply. When the adjustment to the conversion rate is made, the amount previously recorded in “right to recover for covered losses” as contra-equity is then recorded against the book value of the preferred stock within stockholders’ equity. The following table presents the activities related to VE territory covered losses in preferred stock and “right to recover for covered losses” within stockholders’ equity: Preferred Stock Right to Recover for Covered Losses Series B Series C (in millions) Balance as of September 30, 2022 $ 460 $ 812 $ (35) VE territory covered losses incurred (1) — — (8) Recovery through conversion rate adjustment (2) (7) (7) 15 Balance as of December 31, 2022 $ 453 $ 805 $ (28) Preferred Stock Right to Recover for Covered Losses Series B Series C (in millions) Balance as of September 30, 2021 $ 1,071 $ 1,523 $ (133) VE territory covered losses incurred (1) — — (7) Recovery through conversion rate adjustment (26) (3) 29 Balance as of December 31, 2021 $ 1,045 $ 1,520 $ (111) (1) VE territory covered losses incurred reflect settlements with merchants and additional legal costs. See Note 12—Legal Matters . (2) Adjustment to right to recover for covered losses for the conversion rate adjustment differs from the actual recovered amount due to differences in foreign exchange rates between the time the losses were incurred and the subsequent recovery through the conversion rate adjustment. The following table presents the as-converted value of the preferred stock available to recover VE territory covered losses compared to the book value of preferred stock recorded in stockholders’ equity within the Company’s consolidated balance sheets: December 31, 2022 September 30, 2022 As-converted Value of Preferred Stock (1),(2) Book Value of Preferred Stock (1) As-converted Value of Preferred Stock (1),(3) Book Value of Preferred Stock (1) (in millions) Series B preferred stock $ 1,524 $ 453 $ 1,309 $ 460 Series C preferred stock 2,383 805 2,044 812 Total 3,907 1,258 3,353 1,272 Less: right to recover for covered losses (28) (28) (35) (35) Total recovery for covered losses available $ 3,879 $ 1,230 $ 3,318 $ 1,237 (1) Figures in the table may not recalculate exactly due to rounding. As-converted and book values are based on unrounded numbers. (2) As of December 31, 2022, the as-converted value of preferred stock is calculated as the product of: (a) 2 million and 3 million shares of the series B and C preferred stock outstanding, respectively; (b) 2.958 and 3.634, the class A common stock conversion rate applicable to the series B and C preferred stock outstanding, respectively; and (c) $207.76, Visa’s class A common stock closing stock price. (3) As of September 30, 2022, the as-converted value of preferred stock is calculated as the product of: (a) 2 million and 3 million shares of the series B and C preferred stock outstanding, respectively; (b) 2.971 and 3.645, the class A common stock conversion rate applicable to the series B and C preferred stock outstanding, respectively; and (c) $177.65, Visa’s class A common stock closing stock price. |
Fair Value Measurements and Inv
Fair Value Measurements and Investments | 3 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements and Investments | Note 5—Fair Value Measurements and Investments Assets and Liabilities Measured at Fair Value on a Recurring Basis Fair Value Measurements Level 1 Level 2 December 31, September 30, December 31, September 30, (in millions) Assets Cash equivalents and restricted cash equivalents: Money market funds $ 10,078 $ 11,736 $ — $ — U.S. government-sponsored debt securities — — 400 — U.S. Treasury securities 180 799 — — Investment securities: Marketable equity securities 346 437 — — U.S. government-sponsored debt securities — — 964 457 U.S. Treasury securities 4,210 4,005 — — Other current and non-current assets: Money market funds 22 22 — — Derivative instruments — — 245 1,131 Total $ 14,836 $ 16,999 $ 1,609 $ 1,588 Liabilities Accrued compensation and benefits: Deferred compensation liability $ 184 $ 146 $ — $ — Accrued and other liabilities: Derivative instruments — — 398 418 Total $ 184 $ 146 $ 398 $ 418 Level 1 assets and liabilities. Money market funds, marketable equity securities and U.S. Treasury securities are classified as Level 1 within the fair value hierarchy, as fair value is based on unadjusted quoted prices in active markets for identical assets. The Company’s deferred compensation liability is measured at fair value based on marketable equity securities held under the deferred compensation plan. Level 2 assets and liabilities. The fair value of U.S. government-sponsored debt securities, as provided by third-party pricing vendors, is based on quoted prices in active markets for similar, not identical, assets. Derivative instruments are valued using inputs that are observable in the market or can be derived principally from or corroborated by observable market data. U.S. Government-sponsored Debt Securities and U.S. Treasury Securities The amortized cost, unrealized gains and losses and fair value of debt securities were as follows: December 31, 2022 Amortized Gross Unrealized Fair Gains Losses (in millions) U.S. government-sponsored debt securities $ 1,364 $ 1 $ (1) $ 1,364 U.S. Treasury securities 4,509 2 (121) 4,390 Total $ 5,873 $ 3 $ (122) $ 5,754 September 30, 2022 Amortized Gross Unrealized Fair Gains Losses (in millions) U.S. government-sponsored debt securities $ 458 $ — $ (1) $ 457 U.S. Treasury securities 4,937 — (133) 4,804 Total $ 5,395 $ — $ (134) $ 5,261 Debt securities with unrealized losses for less than 12 months and 12 months or greater were as follows: December 31, 2022 Less Than 12 Months 12 Months or Greater Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses (in millions) U.S. government-sponsored debt securities $ 347 $ (1) $ — $ — U.S. Treasury securities 1,598 (38) 1,966 (83) Total $ 1,945 $ (39) $ 1,966 $ (83) September 30, 2022 Less Than 12 Months Fair Value Gross Unrealized Losses (in millions) U.S. government-sponsored debt securities $ 408 $ (1) U.S. Treasury securities 3,507 (133) Total $ 3,915 $ (134) The unrealized losses were primarily attributable to changes in interest rates. The stated maturities of debt securities were as follows: December 31, (in millions) Due within one year $ 3,019 Due after 1 year through 5 years 2,735 Total $ 5,754 Equity Securities The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. These investments are measured at fair value on a non-recurring basis and are classified as Level 3 due to the absence of quoted market prices, the inherent lack of liquidity and the fact that inputs used to measure fair value are unobservable and require management’s judgment. The following table summarizes the total carrying value of the Company’s non-marketable equity securities held as of December 31, 2022 including cumulative unrealized gains and losses: December 31, (in millions) Initial cost basis $ 739 Adjustments: Upward adjustments 827 Downward adjustments (including impairment) (349) Carrying amount, end of period $ 1,217 Unrealized gains and losses included in the carrying value of the Company’s non-marketable equity securities still held as of December 31, 2022 and 2021 were as follows: Three Months Ended 2022 2021 (in millions) Upward adjustments $ 17 $ 224 Downward adjustments (including impairment) $ — $ — For the three months ended December 31, 2022 and 2021, the Company recognized net unrealized losses of $102 million and net unrealized gains of $172 million, respectively, on marketable and non-marketable equity securities still held as of quarter end. Other Fair Value Disclosures Debt. Debt instruments are measured at amortized cost on the Company’s unaudited consolidated balance sheets. The fair value of the debt instruments, as provided by third-party pricing vendors, is based on quoted prices in active markets for similar, not identical, assets. If measured at fair value in the financial statements, these instruments would be classified as Level 2 in the fair value hierarchy. As of December 31, 2022, the carrying value and estimated fair value of debt was $20.5 billion and $18.4 billion, respectively. As of September 30, 2022, the carrying value and estimated fair value of debt was $22.5 billion and $19.9 billion, respectively. Other financial instruments not measured at fair value. As of December 31, 2022, the carrying values of settlement receivable and payable and customer collateral are an approximate fair value due to their generally short maturities. If measured at fair value in the financial statements, these financial instruments would be classified as Level 2 in the fair value hierarchy. Non-financial assets. Certain non-financial assets such as goodwill, intangible assets and property, equipment and technology are subject to non-recurring fair value measurements if they are deemed to be impaired. As of December 31, 2022, there were no impairment indicators. |
Debt
Debt | 3 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Debt | Note 6—Debt The Company had outstanding debt as follows: December 31, September 30, Effective Interest Rate (1) (in millions, except percentages) U.S. dollar notes 2.80% Senior Notes due December 2022 $ — $ 2,250 2.89 % 3.15% Senior Notes due December 2025 4,000 4,000 3.26 % 1.90% Senior Notes due April 2027 1,500 1,500 2.02 % 0.75% Senior Notes due August 2027 500 500 0.84 % 2.75% Senior Notes due September 2027 750 750 2.91 % 2.05% Senior Notes due April 2030 1,500 1,500 2.13 % 1.10% Senior Notes due February 2031 1,000 1,000 1.20 % 4.15% Senior Notes due December 2035 1,500 1,500 4.23 % 2.70% Senior Notes due April 2040 1,000 1,000 2.80 % 4.30% Senior Notes due December 2045 3,500 3,500 4.37 % 3.65% Senior Notes due September 2047 750 750 3.73 % 2.00% Senior Notes due August 2050 1,750 1,750 2.09 % Euro notes 1.50% Senior Notes due June 2026 1,447 1,325 1.71 % 2.00% Senior Notes due June 2029 1,072 982 2.13 % 2.375% Senior Notes due June 2034 697 638 2.53 % Total debt 20,966 22,945 Unamortized discounts and debt issuance costs (171) (173) Hedge accounting fair value adjustments (2) (308) (322) Total carrying value of debt $ 20,487 $ 22,450 Reported as: Current maturities of debt $ — $ 2,250 Long-term debt 20,487 20,200 Total carrying value of debt $ 20,487 $ 22,450 (1) Effective interest rates disclosed do not reflect hedge accounting adjustments. (2) Represents the fair value of interest rate swap agreements entered into on a portion of the outstanding senior notes. Senior Notes During the three months ended December 31, 2022, the Company repaid $2.25 billion of principal upon maturity of its senior notes due December 2022. Non-derivative Financial Instrument Designated as a Net Investment Hedge During the three months ended December 31, 2022, the Company designated €1.8 billion of the Euro-denominated fixed-rate senior notes (Euro Notes) issued in June 2022 as a hedge against a portion of the Company’s Euro-denominated net investment in Visa Europe. As of December 31, 2022, all of the €3.0 billion Euro Notes were designated as a net investment hedge. |
Settlement Guarantee Management
Settlement Guarantee Management | 3 Months Ended |
Dec. 31, 2022 | |
Settlement Guarantee Management [Abstract] | |
Settlement Guarantee Management | Note 7—Settlement Guarantee Management The Company indemnifies its clients for settlement losses suffered due to failure of any other client to fund its settlement obligations in accordance with the Visa operating rules. This indemnification creates settlement risk for the Company due to the difference in timing between the date of a payment transaction and the date of subsequent settlement. Historically, the Company has experienced minimal losses as a result of its settlement risk guarantee. However, the Company’s future obligations, which could be material under its guarantees, are not determinable as they are dependent upon future events. The Company’s settlement exposure is limited to the amount of unsettled Visa payment transactions at any point in time, which vary significantly day to day. During the three months ended December 31, 2022, the Company’s maximum daily settlement exposure was $123.5 billion and the average daily settlement exposure was $76.0 billion. The Company maintains and regularly reviews global settlement risk policies and procedures to manage settlement exposure, which may require clients to post collateral if certain credit standards are not met. The Company held the following collateral to manage settlement exposure: December 31, September 30, (in millions) Restricted cash and restricted cash equivalents $ 2,591 $ 2,342 Pledged securities at market value 255 213 Letters of credit 1,659 1,582 Guarantees 984 950 Total $ 5,489 $ 5,087 |
Stockholders' Equity
Stockholders' Equity | 3 Months Ended |
Dec. 31, 2022 | |
Stockholders' Equity Note [Abstract] | |
Stockholders' Equity | Note 8—Stockholders’ Equity As-converted class A common stock. The number of shares of each series and class, and the number of shares of class A common stock on an as-converted basis were as follows: December 31, 2022 September 30, 2022 Shares Conversion Rate Into As-converted Class A Common Stock (1) Shares Conversion Rate Into As-converted Class A Common Stock (1) (in millions, except conversion rate) Series A preferred stock — (2) 100.0000 11 — (2) 100.0000 16 Series B preferred stock 2 2.9580 7 2 2.9710 7 Series C preferred stock 3 3.6340 11 3 3.6450 12 Class A common stock (3) 1,626 — 1,626 1,635 — 1,635 Class B common stock 245 1.5991 (4) 393 245 1.6059 (4) 394 Class C common stock 10 4.0000 39 10 4.0000 39 Total 2,087 2,103 (1) Figures in the table may not recalculate exactly due to rounding. As-converted class A common stock is calculated based on unrounded numbers. (2) The number of shares outstanding was less than one million. (3) Class A common stock shares outstanding reflect repurchases that settled on or before December 31, 2022 and September 30, 2022. (4) The class B to class A common stock conversion rate is presented on a rounded basis. Conversion calculations for dividend payments are based on a conversion rate rounded to the tenth decimal. Reduction in as-converted shares. The following table presents the reduction in the number of as-converted class B common stock after deposit into the U.S. litigation escrow account for the three months ended December 31, 2022 and 2021. Three Months Ended 2022 2021 (in millions, except per share data) Reduction in equivalent number of class A common stock 2 1 Effective price per share (1) $ 209.14 $ 217.61 Deposits under the U.S. retrospective responsibility plan $ 350 $ 250 (1) Effective price per share is calculated using the volume-weighted average price of the Company’s class A common stock over a pricing period in accordance with the Company’s current certificate of incorporation. The following table presents the reduction in the number of as-converted series B and C preferred stock after the Company recovered VE territory covered losses through conversion rate adjustments: Three Months Ended Three Months Ended Series B Series C Series B Series C (in millions, except per share data) Reduction in equivalent number of class A common stock — (1) — (1) — (1) — (1) Effective price per share (2) $ 211.34 $ 211.34 $ 201.68 $ 201.68 Recovery through conversion rate adjustment $ 7 $ 7 $ 26 $ 3 (1) The reduction in equivalent number of shares of class A common stock was less than one million shares. (2) Effective price per share for the quarter is calculated using the volume-weighted average price of the Company’s class A common stock over a pricing period in accordance with the Company’s current certificates of designations for its series B and C preferred stock. Common stock repurchases. The following table presents share repurchases in the open market: Three Months Ended 2022 2021 (in millions, except per share data) Shares repurchased in the open market (1) 16 19 Average repurchase price per share (2) $ 197.69 $ 210.32 Total cost (2) $ 3,115 $ 4,104 (1) Shares repurchased in the open market reflect repurchases that settled during the three months ended December 31, 2022 and 2021. All shares repurchased in the open market have been retired and constitute authorized but unissued shares. (2) Figures in the table may not recalculate exactly due to rounding. Average repurchase price per share and total cost are calculated based on unrounded numbers. In October 2022, the Company’s board of directors authorized a $12.0 billion share repurchase program. Previously, in December 2021, the Company’s board of directors authorized a $12.0 billion share repurchase program (December 2021 Program). These authorizations have no expiration date. As of December 31, 2022, the Company’s repurchase programs had remaining authorized funds of $14.1 billion. All share repurchase programs authorized prior to the December 2021 Program have been completed. |
Earnings Per Share
Earnings Per Share | 3 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | Note 9—Earnings Per Share The following table presents earnings per share for the three months ended December 31, 2022: Basic Earnings Per Share Diluted Earnings Per Share Income Allocation (A) (1) Weighted- Earnings per Share = (A)/(B) (2) Income Allocation (A) (1) Weighted- Earnings per Share = (A)/(B) (2) (in millions, except per share data) Class A common stock $ 3,243 1,629 $ 1.99 $ 4,179 2,102 (3) $ 1.99 Class B common stock 784 245 $ 3.19 $ 784 245 $ 3.19 Class C common stock 78 10 $ 7.96 $ 78 10 $ 7.95 Participating securities 74 Not presented Not presented $ 74 Not presented Not presented Net income $ 4,179 The following table presents earnings per share for the three months ended December 31, 2021: Basic Earnings Per Share Diluted Earnings Per Share Income Allocation (A) (1) Weighted- Earnings per Share = (A)/(B) (2) Income Allocation (A) (1) Weighted- Earnings per Share = (A)/(B) (2) (in millions, except per share data) Class A common stock $ 3,065 1,669 $ 1.84 $ 3,959 2,159 (3) $ 1.83 Class B common stock 732 245 $ 2.98 $ 731 245 $ 2.98 Class C common stock 74 10 $ 7.35 $ 74 10 $ 7.34 Participating securities 88 Not presented Not presented $ 88 Not presented Not presented Net income $ 3,959 (1) The weighted-average number of shares of as-converted class B common stock used in the income allocation was 394 million and 398 million for the three months ended December 31, 2022 and 2021, respectively. The weighted-average number of shares of as-converted class C common stock used in the income allocation was 39 million and 40 million for the three months ended December 31, 2022 and 2021, respectively. The weighted-average number of shares of preferred stock included within participating securities was 13 million and 7 million of as-converted series A preferred stock for the three months ended December 31, 2022 and 2021, respectively, 7 million and 16 million of as-converted series B preferred stock for the three months ended December 31, 2022 and 2021, respectively, and 11 million and 22 million of as-converted series C preferred stock for the three months ended December 31, 2022 and 2021, respectively. (2) Figures in the table may not recalculate exactly due to rounding. Basic and diluted earnings per share are calculated based on unrounded numbers. (3) Weighted-average diluted shares outstanding are calculated on an as-converted basis and include incremental common stock equivalents, as calculated under the treasury stock method. The common stock equivalents are not material for the three months ended December 31, 2022 and 2021. |
Share-based Compensation
Share-based Compensation | 3 Months Ended |
Dec. 31, 2022 | |
Share-Based Payment Arrangement, Noncash Expense [Abstract] | |
Share-based Compensation | Note 10—Share-based Compensation The following table presents the equity awards granted to employees and non-employee directors under the 2007 Equity Incentive Compensation Plan (EIP) during the three months ended December 31, 2022: Granted Weighted-Average Grant Date Fair Value Weighted-Average Exercise Price Non-qualified stock options 785,254 $ 57.29 $ 210.80 Restricted stock units 2,998,777 $ 210.18 Performance-based shares (1) 457,178 $ 216.08 (1) Represents the maximum number of performance-based shares which could be earned. For the three months ended December 31, 2022 and 2021, the Company recorded share-based compensation cost related to the EIP of $170 million and $121 million, respectively. |
Income Taxes
Income Taxes | 3 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Note 11—Income Taxes For the three months ended December 31, 2022 and 2021, the effective income tax rates were 16% and 19%, respectively. The difference in the effective tax rates is primarily due to a $142 million tax benefit related to prior years recognized during the three months ended December 31, 2022 due to the reassessment of an uncertain tax position as a result of new information obtained during an ongoing tax examination. During the three months ended December 31, 2022, the Company’s gross and net unrecognized tax benefits decreased by $108 million and $149 million, respectively. The decrease in unrecognized tax benefits is primarily related to the reassessment mentioned above, partially offset by an increase in gross timing differences as well as various tax positions across several jurisdictions. The Company’s tax filings are subject to examination by U.S. federal, state and foreign taxing authorities. The timing and outcome of the final resolutions of the various ongoing income tax examinations are highly uncertain. It is not reasonably possible to estimate the increase or decrease in unrecognized tax benefits within the next twelve months. |
Legal Matters
Legal Matters | 3 Months Ended |
Dec. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Legal Matters | Note 12—Legal Matters The Company is party to various legal and regulatory proceedings. Some of these proceedings involve complex claims that are subject to substantial uncertainties and unascertainable damages. For those proceedings where a loss is determined to be only reasonably possible or probable but not estimable, the Company has disclosed the nature of the claim. Additionally, unless otherwise disclosed below with respect to these proceedings, the Company cannot provide an estimate of the possible loss or range of loss. Although the Company believes that it has strong defenses for the litigation and regulatory proceedings described below, it could, in the future, incur judgments or fines or enter into settlements of claims that could have a material adverse effect on the Company’s financial position, results of operations or cash flows. From time to time, the Company may engage in settlement discussions or mediations with respect to one or more of its outstanding litigation matters, either on its own behalf or collectively with other parties. The litigation accrual is an estimate and is based on management’s understanding of its litigation profile, the specifics of each case, advice of counsel to the extent appropriate and management’s best estimate of incurred loss as of the balance sheet date. The following table summarizes the activity related to accrued litigation: Three Months Ended 2022 2021 (in millions) Balance at beginning of period $ 1,456 $ 983 Provision for uncovered legal matters — 1 Provision for covered legal matters 347 146 Payments for legal matters (101) (103) Balance at end of period $ 1,702 $ 1,027 Accrual Summary—U.S. Covered Litigation Visa Inc., Visa U.S.A. and Visa International are parties to certain legal proceedings that are covered by the U.S. retrospective responsibility plan, which the Company refers to as the U.S. covered litigation. An accrual for the U.S. covered litigation and a charge to the litigation provision are recorded when a loss is deemed to be probable and reasonably estimable. In making this determination, the Company evaluates available information, including but not limited to actions taken by the Company’s litigation committee. The total accrual related to the U.S. covered litigation could be either higher or lower than the escrow account balance. See further discussion below under U.S. Covered Litigation and Note 4—U.S. and Europe Retrospective Responsibility Plans. The following table summarizes the accrual activity related to U.S. covered litigation: Three Months Ended 2022 2021 (in millions) Balance at beginning of period $ 1,441 $ 881 Provision for interchange multidistrict litigation 341 145 Payments for U.S. covered litigation (101) — Balance at end of period $ 1,681 $ 1,026 During the three months ended December 31, 2022, the Company recorded an additional accrual of $341 million and deposited $350 million into the U.S. litigation escrow account to address claims associated with the interchange multidistrict litigation. The U.S. covered litigation accrual balance is consistent with the Company’s best estimate of its share of a probable and reasonably estimable loss with respect to U.S. covered litigation. While this estimate is consistent with the Company’s view of the current status of the litigation, the probable and reasonably estimable loss or range of such loss could materially vary based on developments in the litigation. The Company will continue to consider and reevaluate this estimate in light of the substantial uncertainties with respect to the litigation. The Company is unable to estimate a potential loss or range of loss, if any, at trial if negotiated resolutions cannot be reached. Accrual Summary—VE Territory Covered Litigation Visa Inc., Visa International and Visa Europe are parties to certain legal proceedings that are covered by the Europe retrospective responsibility plan. Unlike the U.S. retrospective responsibility plan, the Europe retrospective responsibility plan does not have an escrow account that is used to fund settlements or judgments. The Company is entitled to recover VE territory covered losses through periodic adjustments to the conversion rates applicable to the series B and C preferred stock. An accrual for the VE territory covered losses and a reduction to stockholders’ equity will be recorded when the loss is deemed to be probable and reasonably estimable. See further discussion below under VE Territory Covered Litigation and Note 4—U.S. and Europe Retrospective Responsibility Plans . The following table summarizes the accrual activity related to VE territory covered litigation: Three Months Ended 2022 2021 (in millions) Balance at beginning of period $ 11 $ 102 Provision for VE territory covered litigation 6 1 Payments for VE territory covered litigation — (102) Balance at end of period $ 17 $ 1 U.S. Covered Litigation Interchange Multidistrict Litigation (MDL) - Individual Merchant Actions Visa has reached settlements with a number of merchants representing approximately 62% of the Visa-branded payment card sales volume of merchants who opted out of the Amended Settlement Agreement with the Damages Class plaintiffs. VE Territory Covered Litigation Europe Merchant Litigation Since July 2013, proceedings have been commenced by more than 900 Merchants (the capitalized term “Merchant” when used in this section, means a Merchant together with subsidiary/affiliate companies that are party to the same claim) against Visa Europe, Visa Inc. and other Visa subsidiaries in the UK and other countries primarily relating to interchange rates in Europe and in some cases relating to fees charged by Visa and certain Visa rules. As of the filing date, Visa has settled the claims asserted by over 150 Merchants, and there are approximately 700 Merchants with outstanding claims. In addition, over 30 additional Merchants have threatened to commence similar proceedings. Standstill agreements have been entered into with respect to some of those threatened Merchant claims, several of which have been settled. Other Litigation EMV Chip Liability Shift On November 30, 2022, Visa, jointly with other defendants, served a motion for summary judgment regarding the claims in the amended complaint and a motion to decertify the class. U.S. Department of Justice Civil Investigative Demand (2021) On January 4, 2023, the Antitrust Division of the U.S. Department of Justice (Division) issued a further Civil Investigative Demand seeking additional documents and information focusing on U.S. debit and competition with other payment methods and networks. Visa is cooperating with the Division in connection with the investigation. Foreign Currency Exchange Rate Litigation On December 21, 2022, plaintiffs filed a third amended complaint asserting the same claims as asserted in the prior complaints. European Commission Client Incentive Agreements Investigation On December 2, 2022, the European Commission (EC) informed Visa that it had opened a preliminary investigation into Visa’s incentive agreements with clients. Visa is cooperating with the EC in connection with the investigation. Consumer Interchange Litigation On December 30, 2022, a putative class action was filed in California state court against Visa, Mastercard, and certain financial institutions on behalf of all Visa and Mastercard cardholders in California who made a purchase using a Visa-branded or Mastercard-branded payment card in California from January 1, 2004. Plaintiffs primarily allege a conspiracy to fix interchange fees and seek injunctive relief, attorneys’ fees and damages as direct and indirect purchasers based on alleged violations of California law. On January 11, 2023, plaintiffs filed an amended complaint asserting the same claims as asserted in the prior complaint. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Consolidation and basis of presentation | Consolidation and basis of presentation. The accompanying unaudited consolidated financial statements include the accounts of Visa and its consolidated entities and are presented in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). The Company consolidates its majority-owned and controlled entities, including variable interest entities (VIEs) for which the Company is the primary beneficiary. The Company’s investments in VIEs have not been material to its unaudited consolidated financial statements as of and for the periods presented. All significant intercompany accounts and transactions are eliminated in consolidation. The accompanying unaudited consolidated financial statements are presented in accordance with U.S. Securities and Exchange Commission (SEC) requirements for Quarterly Reports on Form 10-Q and, consequently, do not include all of the annual disclosures required by U.S. GAAP. Reference should be made to the Visa Annual Report on Form 10-K for the year ended September 30, 2022 for additional disclosures, including a summary of the Company’s significant accounting policies. In the opinion of management, the accompanying unaudited consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods presented. The results of operations for interim periods are not necessarily indicative of results for the full year. |
Use of estimates | Use of estimates. The preparation of the accompanying unaudited consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and reported amounts of revenues and expenses during the reporting period. These estimates may change as new events occur and additional information is obtained, and will be recognized in the period in which such changes occur. Future actual results could differ materially from these estimates. |
Revenues (Tables)
Revenues (Tables) | 3 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Disaggregation of Revenue | The following tables disaggregate the Company’s net revenues by revenue category and by geography: Three Months Ended 2022 2021 (in millions) Service revenues $ 3,511 $ 3,193 Data processing revenues 3,827 3,614 International transaction revenues 2,797 2,174 Other revenues 587 449 Client incentives (2,786) (2,371) Net revenues $ 7,936 $ 7,059 Three Months Ended 2022 2021 (in millions) U.S. $ 3,567 $ 3,178 International 4,369 3,881 Net revenues $ 7,936 $ 7,059 |
Cash, Cash Equivalents, Restr_2
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Tables) | 3 Months Ended |
Dec. 31, 2022 | |
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] | |
Schedule of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | The Company reconciles cash, cash equivalents, restricted cash and restricted cash equivalents reported in the consolidated balance sheets that aggregate to the beginning and ending balances shown in the consolidated statements of cash flows as follows: December 31, September 30, (in millions) Cash and cash equivalents $ 13,334 $ 15,689 Restricted cash and restricted cash equivalents: U.S. litigation escrow 1,705 1,449 Customer collateral 2,591 2,342 Prepaid expenses and other current assets 753 897 Cash, cash equivalents, restricted cash and restricted cash equivalents $ 18,383 $ 20,377 |
U.S. and Europe Retrospective_2
U.S. and Europe Retrospective Responsibility Plans (Tables) | 3 Months Ended |
Dec. 31, 2022 | |
Retrospective Responsibility Plans [Abstract] | |
Changes in the U.S. litigation escrow account | The following table presents the changes in the restricted cash equivalents—U.S. litigation escrow account: Three Months Ended 2022 2021 (in millions) Balance at beginning of period $ 1,449 $ 894 Deposits into the litigation escrow account 350 250 Payments to opt-out merchants (1) , net of interest earned on escrow funds (94) — Balance at end of period $ 1,705 $ 1,144 (1) These payments are associated with the interchange multidistrict litigation. See Note 12—Legal Matters . |
Changes in Preferred Stock and Right to Recover for Covered Losses | The following table presents the activities related to VE territory covered losses in preferred stock and “right to recover for covered losses” within stockholders’ equity: Preferred Stock Right to Recover for Covered Losses Series B Series C (in millions) Balance as of September 30, 2022 $ 460 $ 812 $ (35) VE territory covered losses incurred (1) — — (8) Recovery through conversion rate adjustment (2) (7) (7) 15 Balance as of December 31, 2022 $ 453 $ 805 $ (28) Preferred Stock Right to Recover for Covered Losses Series B Series C (in millions) Balance as of September 30, 2021 $ 1,071 $ 1,523 $ (133) VE territory covered losses incurred (1) — — (7) Recovery through conversion rate adjustment (26) (3) 29 Balance as of December 31, 2021 $ 1,045 $ 1,520 $ (111) (1) VE territory covered losses incurred reflect settlements with merchants and additional legal costs. See Note 12—Legal Matters . |
Preferred Stock As-Converted Value and Book Value | The following table presents the as-converted value of the preferred stock available to recover VE territory covered losses compared to the book value of preferred stock recorded in stockholders’ equity within the Company’s consolidated balance sheets: December 31, 2022 September 30, 2022 As-converted Value of Preferred Stock (1),(2) Book Value of Preferred Stock (1) As-converted Value of Preferred Stock (1),(3) Book Value of Preferred Stock (1) (in millions) Series B preferred stock $ 1,524 $ 453 $ 1,309 $ 460 Series C preferred stock 2,383 805 2,044 812 Total 3,907 1,258 3,353 1,272 Less: right to recover for covered losses (28) (28) (35) (35) Total recovery for covered losses available $ 3,879 $ 1,230 $ 3,318 $ 1,237 (1) Figures in the table may not recalculate exactly due to rounding. As-converted and book values are based on unrounded numbers. (2) As of December 31, 2022, the as-converted value of preferred stock is calculated as the product of: (a) 2 million and 3 million shares of the series B and C preferred stock outstanding, respectively; (b) 2.958 and 3.634, the class A common stock conversion rate applicable to the series B and C preferred stock outstanding, respectively; and (c) $207.76, Visa’s class A common stock closing stock price. (3) As of September 30, 2022, the as-converted value of preferred stock is calculated as the product of: (a) 2 million and 3 million shares of the series B and C preferred stock outstanding, respectively; (b) 2.971 and 3.645, the class A common stock conversion rate applicable to the series B and C preferred stock outstanding, respectively; and (c) $177.65, Visa’s class A common stock closing stock price. |
Fair Value Measurements and I_2
Fair Value Measurements and Investments (Tables) | 3 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis | Assets and Liabilities Measured at Fair Value on a Recurring Basis Fair Value Measurements Level 1 Level 2 December 31, September 30, December 31, September 30, (in millions) Assets Cash equivalents and restricted cash equivalents: Money market funds $ 10,078 $ 11,736 $ — $ — U.S. government-sponsored debt securities — — 400 — U.S. Treasury securities 180 799 — — Investment securities: Marketable equity securities 346 437 — — U.S. government-sponsored debt securities — — 964 457 U.S. Treasury securities 4,210 4,005 — — Other current and non-current assets: Money market funds 22 22 — — Derivative instruments — — 245 1,131 Total $ 14,836 $ 16,999 $ 1,609 $ 1,588 Liabilities Accrued compensation and benefits: Deferred compensation liability $ 184 $ 146 $ — $ — Accrued and other liabilities: Derivative instruments — — 398 418 Total $ 184 $ 146 $ 398 $ 418 |
Schedule of Amortized Cost, Unrealized Gains and Losses, and Fair Value of Debt Securities | The amortized cost, unrealized gains and losses and fair value of debt securities were as follows: December 31, 2022 Amortized Gross Unrealized Fair Gains Losses (in millions) U.S. government-sponsored debt securities $ 1,364 $ 1 $ (1) $ 1,364 U.S. Treasury securities 4,509 2 (121) 4,390 Total $ 5,873 $ 3 $ (122) $ 5,754 September 30, 2022 Amortized Gross Unrealized Fair Gains Losses (in millions) U.S. government-sponsored debt securities $ 458 $ — $ (1) $ 457 U.S. Treasury securities 4,937 — (133) 4,804 Total $ 5,395 $ — $ (134) $ 5,261 Debt securities with unrealized losses for less than 12 months and 12 months or greater were as follows: December 31, 2022 Less Than 12 Months 12 Months or Greater Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses (in millions) U.S. government-sponsored debt securities $ 347 $ (1) $ — $ — U.S. Treasury securities 1,598 (38) 1,966 (83) Total $ 1,945 $ (39) $ 1,966 $ (83) September 30, 2022 Less Than 12 Months Fair Value Gross Unrealized Losses (in millions) U.S. government-sponsored debt securities $ 408 $ (1) U.S. Treasury securities 3,507 (133) Total $ 3,915 $ (134) |
Debt Securities Classified by Contractual Maturity Date | The stated maturities of debt securities were as follows: December 31, (in millions) Due within one year $ 3,019 Due after 1 year through 5 years 2,735 Total $ 5,754 |
Schedule of Non-Marketable Equity Securities | The following table summarizes the total carrying value of the Company’s non-marketable equity securities held as of December 31, 2022 including cumulative unrealized gains and losses: December 31, (in millions) Initial cost basis $ 739 Adjustments: Upward adjustments 827 Downward adjustments (including impairment) (349) Carrying amount, end of period $ 1,217 Unrealized gains and losses included in the carrying value of the Company’s non-marketable equity securities still held as of December 31, 2022 and 2021 were as follows: Three Months Ended 2022 2021 (in millions) Upward adjustments $ 17 $ 224 Downward adjustments (including impairment) $ — $ — |
Debt (Tables)
Debt (Tables) | 3 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Schedule of Debt | The Company had outstanding debt as follows: December 31, September 30, Effective Interest Rate (1) (in millions, except percentages) U.S. dollar notes 2.80% Senior Notes due December 2022 $ — $ 2,250 2.89 % 3.15% Senior Notes due December 2025 4,000 4,000 3.26 % 1.90% Senior Notes due April 2027 1,500 1,500 2.02 % 0.75% Senior Notes due August 2027 500 500 0.84 % 2.75% Senior Notes due September 2027 750 750 2.91 % 2.05% Senior Notes due April 2030 1,500 1,500 2.13 % 1.10% Senior Notes due February 2031 1,000 1,000 1.20 % 4.15% Senior Notes due December 2035 1,500 1,500 4.23 % 2.70% Senior Notes due April 2040 1,000 1,000 2.80 % 4.30% Senior Notes due December 2045 3,500 3,500 4.37 % 3.65% Senior Notes due September 2047 750 750 3.73 % 2.00% Senior Notes due August 2050 1,750 1,750 2.09 % Euro notes 1.50% Senior Notes due June 2026 1,447 1,325 1.71 % 2.00% Senior Notes due June 2029 1,072 982 2.13 % 2.375% Senior Notes due June 2034 697 638 2.53 % Total debt 20,966 22,945 Unamortized discounts and debt issuance costs (171) (173) Hedge accounting fair value adjustments (2) (308) (322) Total carrying value of debt $ 20,487 $ 22,450 Reported as: Current maturities of debt $ — $ 2,250 Long-term debt 20,487 20,200 Total carrying value of debt $ 20,487 $ 22,450 (1) Effective interest rates disclosed do not reflect hedge accounting adjustments. |
Settlement Guarantee Manageme_2
Settlement Guarantee Management (Tables) | 3 Months Ended |
Dec. 31, 2022 | |
Settlement Guarantee Management [Abstract] | |
Schedule of Customer Collateral | The Company held the following collateral to manage settlement exposure: December 31, September 30, (in millions) Restricted cash and restricted cash equivalents $ 2,591 $ 2,342 Pledged securities at market value 255 213 Letters of credit 1,659 1,582 Guarantees 984 950 Total $ 5,489 $ 5,087 |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 3 Months Ended |
Dec. 31, 2022 | |
Stockholders' Equity Note [Abstract] | |
Schedule of Stock by Class | As-converted class A common stock. The number of shares of each series and class, and the number of shares of class A common stock on an as-converted basis were as follows: December 31, 2022 September 30, 2022 Shares Conversion Rate Into As-converted Class A Common Stock (1) Shares Conversion Rate Into As-converted Class A Common Stock (1) (in millions, except conversion rate) Series A preferred stock — (2) 100.0000 11 — (2) 100.0000 16 Series B preferred stock 2 2.9580 7 2 2.9710 7 Series C preferred stock 3 3.6340 11 3 3.6450 12 Class A common stock (3) 1,626 — 1,626 1,635 — 1,635 Class B common stock 245 1.5991 (4) 393 245 1.6059 (4) 394 Class C common stock 10 4.0000 39 10 4.0000 39 Total 2,087 2,103 (1) Figures in the table may not recalculate exactly due to rounding. As-converted class A common stock is calculated based on unrounded numbers. (2) The number of shares outstanding was less than one million. (3) Class A common stock shares outstanding reflect repurchases that settled on or before December 31, 2022 and September 30, 2022. (4) The class B to class A common stock conversion rate is presented on a rounded basis. Conversion calculations for dividend payments are based on a conversion rate rounded to the tenth decimal. |
Effect of VE Territory Covered Losses Recovery on the Company Repurchasing its Common Stock | The following table presents the reduction in the number of as-converted class B common stock after deposit into the U.S. litigation escrow account for the three months ended December 31, 2022 and 2021. Three Months Ended 2022 2021 (in millions, except per share data) Reduction in equivalent number of class A common stock 2 1 Effective price per share (1) $ 209.14 $ 217.61 Deposits under the U.S. retrospective responsibility plan $ 350 $ 250 (1) Effective price per share is calculated using the volume-weighted average price of the Company’s class A common stock over a pricing period in accordance with the Company’s current certificate of incorporation. |
Effect of VE Territory Covered Losses Recovery on the Company Repurchasing its Common Stock | The following table presents the reduction in the number of as-converted series B and C preferred stock after the Company recovered VE territory covered losses through conversion rate adjustments: Three Months Ended Three Months Ended Series B Series C Series B Series C (in millions, except per share data) Reduction in equivalent number of class A common stock — (1) — (1) — (1) — (1) Effective price per share (2) $ 211.34 $ 211.34 $ 201.68 $ 201.68 Recovery through conversion rate adjustment $ 7 $ 7 $ 26 $ 3 (1) The reduction in equivalent number of shares of class A common stock was less than one million shares. (2) Effective price per share for the quarter is calculated using the volume-weighted average price of the Company’s class A common stock over a pricing period in accordance with the Company’s current certificates of designations for its series B and C preferred stock. |
Share Repurchase Program Disclosure | Common stock repurchases. The following table presents share repurchases in the open market: Three Months Ended 2022 2021 (in millions, except per share data) Shares repurchased in the open market (1) 16 19 Average repurchase price per share (2) $ 197.69 $ 210.32 Total cost (2) $ 3,115 $ 4,104 (1) Shares repurchased in the open market reflect repurchases that settled during the three months ended December 31, 2022 and 2021. All shares repurchased in the open market have been retired and constitute authorized but unissued shares. (2) Figures in the table may not recalculate exactly due to rounding. Average repurchase price per share and total cost are calculated based on unrounded numbers. |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 3 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | The following table presents earnings per share for the three months ended December 31, 2022: Basic Earnings Per Share Diluted Earnings Per Share Income Allocation (A) (1) Weighted- Earnings per Share = (A)/(B) (2) Income Allocation (A) (1) Weighted- Earnings per Share = (A)/(B) (2) (in millions, except per share data) Class A common stock $ 3,243 1,629 $ 1.99 $ 4,179 2,102 (3) $ 1.99 Class B common stock 784 245 $ 3.19 $ 784 245 $ 3.19 Class C common stock 78 10 $ 7.96 $ 78 10 $ 7.95 Participating securities 74 Not presented Not presented $ 74 Not presented Not presented Net income $ 4,179 The following table presents earnings per share for the three months ended December 31, 2021: Basic Earnings Per Share Diluted Earnings Per Share Income Allocation (A) (1) Weighted- Earnings per Share = (A)/(B) (2) Income Allocation (A) (1) Weighted- Earnings per Share = (A)/(B) (2) (in millions, except per share data) Class A common stock $ 3,065 1,669 $ 1.84 $ 3,959 2,159 (3) $ 1.83 Class B common stock 732 245 $ 2.98 $ 731 245 $ 2.98 Class C common stock 74 10 $ 7.35 $ 74 10 $ 7.34 Participating securities 88 Not presented Not presented $ 88 Not presented Not presented Net income $ 3,959 (1) The weighted-average number of shares of as-converted class B common stock used in the income allocation was 394 million and 398 million for the three months ended December 31, 2022 and 2021, respectively. The weighted-average number of shares of as-converted class C common stock used in the income allocation was 39 million and 40 million for the three months ended December 31, 2022 and 2021, respectively. The weighted-average number of shares of preferred stock included within participating securities was 13 million and 7 million of as-converted series A preferred stock for the three months ended December 31, 2022 and 2021, respectively, 7 million and 16 million of as-converted series B preferred stock for the three months ended December 31, 2022 and 2021, respectively, and 11 million and 22 million of as-converted series C preferred stock for the three months ended December 31, 2022 and 2021, respectively. (2) Figures in the table may not recalculate exactly due to rounding. Basic and diluted earnings per share are calculated based on unrounded numbers. (3) Weighted-average diluted shares outstanding are calculated on an as-converted basis and include incremental common stock equivalents, as calculated under the treasury stock method. The common stock equivalents are not material for the three months ended December 31, 2022 and 2021. |
Share-based Compensation (Table
Share-based Compensation (Tables) | 3 Months Ended |
Dec. 31, 2022 | |
Share-Based Payment Arrangement, Noncash Expense [Abstract] | |
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award | The following table presents the equity awards granted to employees and non-employee directors under the 2007 Equity Incentive Compensation Plan (EIP) during the three months ended December 31, 2022: Granted Weighted-Average Grant Date Fair Value Weighted-Average Exercise Price Non-qualified stock options 785,254 $ 57.29 $ 210.80 Restricted stock units 2,998,777 $ 210.18 Performance-based shares (1) 457,178 $ 216.08 (1) Represents the maximum number of performance-based shares which could be earned. |
Legal Matters (Tables)
Legal Matters (Tables) | 3 Months Ended |
Dec. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of Loss Contingencies by Contingency | The following table summarizes the activity related to accrued litigation: Three Months Ended 2022 2021 (in millions) Balance at beginning of period $ 1,456 $ 983 Provision for uncovered legal matters — 1 Provision for covered legal matters 347 146 Payments for legal matters (101) (103) Balance at end of period $ 1,702 $ 1,027 The following table summarizes the accrual activity related to U.S. covered litigation: Three Months Ended 2022 2021 (in millions) Balance at beginning of period $ 1,441 $ 881 Provision for interchange multidistrict litigation 341 145 Payments for U.S. covered litigation (101) — Balance at end of period $ 1,681 $ 1,026 The following table summarizes the accrual activity related to VE territory covered litigation: Three Months Ended 2022 2021 (in millions) Balance at beginning of period $ 11 $ 102 Provision for VE territory covered litigation 6 1 Payments for VE territory covered litigation — (102) Balance at end of period $ 17 $ 1 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Details) | Dec. 31, 2022 country |
Accounting Policies [Abstract] | |
Number of countries in which Visa operates (more than) | 200 |
Revenues - Schedule of Net Reve
Revenues - Schedule of Net Revenues (Details) - USD ($) $ in Millions | 3 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Disaggregation of Revenue [Line Items] | ||
Net revenues | $ 7,936 | $ 7,059 |
U.S. | ||
Disaggregation of Revenue [Line Items] | ||
Net revenues | 3,567 | 3,178 |
International | ||
Disaggregation of Revenue [Line Items] | ||
Net revenues | 4,369 | 3,881 |
Service revenues | ||
Disaggregation of Revenue [Line Items] | ||
Net revenues | 3,511 | 3,193 |
Data processing revenues | ||
Disaggregation of Revenue [Line Items] | ||
Net revenues | 3,827 | 3,614 |
International transaction revenues | ||
Disaggregation of Revenue [Line Items] | ||
Net revenues | 2,797 | 2,174 |
Other revenues | ||
Disaggregation of Revenue [Line Items] | ||
Net revenues | 587 | 449 |
Client incentives | ||
Disaggregation of Revenue [Line Items] | ||
Net revenues | $ (2,786) | $ (2,371) |
Cash, Cash Equivalents, Restr_3
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details) - USD ($) $ in Millions | Dec. 31, 2022 | Sep. 30, 2022 | Dec. 31, 2021 | Sep. 30, 2021 |
Restricted Cash and Cash Equivalents Items [Line Items] | ||||
Cash and cash equivalents | $ 13,334 | $ 15,689 | ||
Cash, cash equivalents, restricted cash and restricted cash equivalents | 18,383 | 20,377 | $ 18,323 | $ 19,799 |
U.S. litigation escrow | ||||
Restricted Cash and Cash Equivalents Items [Line Items] | ||||
Restricted cash and restricted cash equivalents: | 1,705 | 1,449 | ||
Customer collateral | ||||
Restricted Cash and Cash Equivalents Items [Line Items] | ||||
Restricted cash and restricted cash equivalents: | 2,591 | 2,342 | ||
Prepaid expenses and other current assets | ||||
Restricted Cash and Cash Equivalents Items [Line Items] | ||||
Restricted cash and restricted cash equivalents: | $ 753 | $ 897 |
U.S. and Europe Retrospective_3
U.S. and Europe Retrospective Responsibility Plans - Changes in the U.S. Litigation Escrow Account (Detail) - USD ($) $ in Millions | 3 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Escrow Account [Roll Forward] | ||
Balance at beginning of period | $ 1,449 | $ 894 |
Deposits into the litigation escrow account | 350 | 250 |
Balance at end of period | 1,705 | 1,144 |
Interest Income | Opt-out Merchants | ||
Escrow Account [Roll Forward] | ||
Payments to opt-out merchants, net of interest earned on escrow funds | $ (94) | $ 0 |
U.S. and Europe Retrospective_4
U.S. and Europe Retrospective Responsibility Plans - Additional Details (Details) € in Millions | 3 Months Ended |
Dec. 31, 2022 EUR (€) | |
Retrospective Responsibility Plans [Abstract] | |
VE covered loss, maximum amount of loss to allow adjustment of conversion rate during six-month period | € 20 |
U.S. and Europe Retrospective_5
U.S. and Europe Retrospective Responsibility Plans - Changes in Preferred Stock and Right to Recover Covered Losses (Details) $ / shares in Units, shares in Millions, $ in Millions | 3 Months Ended | |||||
Dec. 31, 2022 USD ($) $ / shares shares | Dec. 31, 2021 USD ($) shares | Sep. 30, 2022 USD ($) $ / shares shares | Sep. 30, 2021 shares | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Beginning balance | $ 35,581 | $ 37,589 | ||||
VE territory covered losses incurred | (8) | (7) | ||||
Recovery through conversion rate adjustment | 1 | 0 | ||||
Ending balance | 36,924 | 36,194 | ||||
As-converted value of Preferred Stock | 3,907 | $ 3,353 | ||||
Book Value of Preferred Stock | 1,981 | 2,324 | ||||
Book Value of Preferred Stock, Total | 1,258 | 1,272 | ||||
Less: right to recover for covered losses | (28) | (35) | ||||
As-converted value of Preferred Stock, Total recovery for covered losses available | 3,879 | 3,318 | ||||
Book value of Preferred of Stock, Total recovery for covered losses available | $ 1,230 | $ 1,237 | ||||
Share price (in dollars per share) | $ / shares | $ 207.76 | $ 177.65 | ||||
Preferred Stock | ||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Beginning balance | $ 2,324 | [1] | 3,080 | [2] | ||
Recovery through conversion rate adjustment | (14) | (29) | ||||
Ending balance | $ 1,981 | [1] | $ 2,995 | [2] | ||
Preferred stock, shares outstanding (in shares) | shares | 5 | 5 | 5 | 5 | ||
Right to Recover for Covered Losses | ||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Beginning balance | $ (35) | $ (133) | ||||
VE territory covered losses incurred | (8) | (7) | ||||
Recovery through conversion rate adjustment | 15 | 29 | ||||
Ending balance | (28) | (111) | ||||
Series B preferred stock | ||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Recovery through conversion rate adjustment | 7 | 26 | ||||
As-converted value of Preferred Stock | 1,524 | $ 1,309 | ||||
Book Value of Preferred Stock | $ 453 | $ 460 | ||||
Preferred stock, shares outstanding (in shares) | shares | 2 | 2 | ||||
Preferred stock, conversion rate | 2.9580 | 2.9710 | ||||
Series B preferred stock | Preferred Stock | ||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Beginning balance | $ 460 | 1,071 | ||||
VE territory covered losses incurred | 0 | 0 | ||||
Recovery through conversion rate adjustment | (7) | (26) | ||||
Ending balance | 453 | 1,045 | ||||
Series C preferred stock | ||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Recovery through conversion rate adjustment | 7 | 3 | ||||
As-converted value of Preferred Stock | 2,383 | $ 2,044 | ||||
Book Value of Preferred Stock | $ 805 | $ 812 | ||||
Preferred stock, shares outstanding (in shares) | shares | 3 | 3 | ||||
Preferred stock, conversion rate | 3.6340 | 3.6450 | ||||
Series C preferred stock | Preferred Stock | ||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Beginning balance | $ 812 | 1,523 | ||||
VE territory covered losses incurred | 0 | 0 | ||||
Recovery through conversion rate adjustment | (7) | (3) | ||||
Ending balance | $ 805 | $ 1,520 | ||||
[1] As of December 31, 2022 and September 30, 2022, the book value of series A preferred stock was $723 million and $1.0 billion, respectively. Refer to Note 4—U.S. and Europe Retrospective Responsibility Plans for the book value of series B and series C preferred stock. As of December 31, 2021 and September 30, 2021, the book value of series A preferred stock was $430 million and $486 million, respectively. Refer to Note 4—U.S. and Europe Retrospective Responsibility Plans for the book value of series B and series C preferred stock. |
Fair Value Measurements and I_3
Fair Value Measurements and Investments - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Millions | Dec. 31, 2022 | Sep. 30, 2022 |
Assets | ||
Investment securities | $ 5,754 | $ 5,261 |
Level 1 | Recurring | ||
Assets | ||
Total | 14,836 | 16,999 |
Liabilities | ||
Total | 184 | 146 |
Level 1 | Recurring | Derivative instruments | ||
Liabilities | ||
Derivative instruments | 0 | 0 |
Level 1 | Recurring | Deferred compensation liability | ||
Liabilities | ||
Deferred compensation liability | 184 | 146 |
Level 1 | Money market funds | Recurring | ||
Assets | ||
Cash equivalents and restricted cash equivalents: | 10,078 | 11,736 |
Other current and non-current assets: | 22 | 22 |
Level 1 | U.S. government-sponsored debt securities | Recurring | ||
Assets | ||
Cash equivalents and restricted cash equivalents: | 0 | 0 |
Investment securities | 0 | 0 |
Level 1 | U.S. Treasury securities | Recurring | ||
Assets | ||
Cash equivalents and restricted cash equivalents: | 180 | 799 |
Investment securities | 4,210 | 4,005 |
Level 1 | Marketable equity securities | Recurring | ||
Assets | ||
Marketable equity securities | 346 | 437 |
Level 1 | Derivative instruments | Recurring | ||
Assets | ||
Other current and non-current assets: | 0 | 0 |
Level 2 | Recurring | ||
Assets | ||
Total | 1,609 | 1,588 |
Liabilities | ||
Total | 398 | 418 |
Level 2 | Recurring | Derivative instruments | ||
Liabilities | ||
Derivative instruments | 398 | 418 |
Level 2 | Recurring | Deferred compensation liability | ||
Liabilities | ||
Deferred compensation liability | 0 | 0 |
Level 2 | Money market funds | Recurring | ||
Assets | ||
Cash equivalents and restricted cash equivalents: | 0 | 0 |
Other current and non-current assets: | 0 | 0 |
Level 2 | U.S. government-sponsored debt securities | Recurring | ||
Assets | ||
Cash equivalents and restricted cash equivalents: | 400 | 0 |
Investment securities | 964 | 457 |
Level 2 | U.S. Treasury securities | Recurring | ||
Assets | ||
Cash equivalents and restricted cash equivalents: | 0 | 0 |
Investment securities | 0 | 0 |
Level 2 | Marketable equity securities | Recurring | ||
Assets | ||
Marketable equity securities | 0 | 0 |
Level 2 | Derivative instruments | Recurring | ||
Assets | ||
Other current and non-current assets: | $ 245 | $ 1,131 |
Fair Value Measurements and I_4
Fair Value Measurements and Investments - Amortized Cost, Unrealized Gains and Losses, and Fair Value of Available-for-Sale Securities (Details) - USD ($) $ in Millions | Dec. 31, 2022 | Sep. 30, 2022 |
Debt Securities, Available-for-Sale [Line Items] | ||
Amortized Cost | $ 5,873 | $ 5,395 |
Gross Unrealized Gains | 3 | 0 |
Gross Unrealized Losses | (122) | (134) |
Fair Value | 5,754 | 5,261 |
U.S. government-sponsored debt securities | ||
Debt Securities, Available-for-Sale [Line Items] | ||
Amortized Cost | 1,364 | 458 |
Gross Unrealized Gains | 1 | 0 |
Gross Unrealized Losses | (1) | (1) |
Fair Value | 1,364 | 457 |
U.S. Treasury securities | ||
Debt Securities, Available-for-Sale [Line Items] | ||
Amortized Cost | 4,509 | 4,937 |
Gross Unrealized Gains | 2 | 0 |
Gross Unrealized Losses | (121) | (133) |
Fair Value | $ 4,390 | $ 4,804 |
Fair Value Measurements and I_5
Fair Value Measurements and Investments - Continuous Unrealized Losses for Less than 12 Months and More than 12 Months (Details) - USD ($) $ in Millions | Dec. 31, 2022 | Sep. 30, 2022 |
Debt Securities, Available-for-Sale [Line Items] | ||
Less Than 12 Months, Fair Value | $ 1,945 | $ 3,915 |
Less Than 12 Months, Gross Unrealized Losses | (39) | (134) |
12 Months or Greater, Fair Value | 1,966 | |
12 Months or Greater, Gross Unrealized Losses | (83) | |
U.S. government-sponsored debt securities | ||
Debt Securities, Available-for-Sale [Line Items] | ||
Less Than 12 Months, Fair Value | 347 | 408 |
Less Than 12 Months, Gross Unrealized Losses | (1) | (1) |
12 Months or Greater, Fair Value | 0 | |
12 Months or Greater, Gross Unrealized Losses | 0 | |
U.S. Treasury securities | ||
Debt Securities, Available-for-Sale [Line Items] | ||
Less Than 12 Months, Fair Value | 1,598 | 3,507 |
Less Than 12 Months, Gross Unrealized Losses | (38) | $ (133) |
12 Months or Greater, Fair Value | 1,966 | |
12 Months or Greater, Gross Unrealized Losses | $ (83) |
Fair Value Measurements and I_6
Fair Value Measurements and Investments - Additional Information (Detail) - USD ($) $ in Millions | 3 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Sep. 30, 2022 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Unrealized gains (losses) on equity securities held as of the end of the period | $ (102) | $ 172 | |
Senior Notes | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Carrying value of debt | 20,500 | $ 22,500 | |
Estimated Fair Value | Senior Notes | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Estimated fair value of debt | $ 18,400 | $ 19,900 |
Fair Value Measurements and I_7
Fair Value Measurements and Investments - Schedule of Non-Marketable Equity Securities (Details) - USD ($) $ in Millions | 3 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Fair Value Disclosures [Abstract] | ||
Initial cost basis | $ 739 | |
Upward adjustments | 827 | |
Downward adjustments (including impairment) | (349) | |
Carrying amount, end of period | 1,217 | |
Upward adjustments | 17 | $ 224 |
Downward adjustments (including impairment) | $ 0 | $ 0 |
Fair Value Measurements and I_8
Fair Value Measurements and Investments - Contractual Maturity of Debt Securities (Details) - USD ($) $ in Millions | Dec. 31, 2022 | Sep. 30, 2022 |
Fair Value Disclosures [Abstract] | ||
Due within one year | $ 3,019 | |
Due after 1 year through 5 years | 2,735 | |
Total | $ 5,754 | $ 5,261 |
Debt - Summary of Debt (Details
Debt - Summary of Debt (Details) - USD ($) $ in Millions | Dec. 31, 2022 | Sep. 30, 2022 |
Debt Instrument [Line Items] | ||
Unamortized discounts and debt issuance costs | $ (171) | $ (173) |
Hedge accounting fair value adjustments | (308) | (322) |
Total carrying value of debt | 20,487 | 22,450 |
Current maturities of debt | 0 | 2,250 |
Long-term debt | 20,487 | 20,200 |
1.50% Senior Notes due June 2026 | Europe | ||
Debt Instrument [Line Items] | ||
Total debt | $ 1,447 | 1,325 |
Effective interest rate (percent) | 1.71% | |
2.00% Senior Notes due June 2029 | Europe | ||
Debt Instrument [Line Items] | ||
Total debt | $ 1,072 | 982 |
Effective interest rate (percent) | 2.13% | |
2.375% Senior Notes due June 2034 | Europe | ||
Debt Instrument [Line Items] | ||
Total debt | $ 697 | 638 |
Effective interest rate (percent) | 2.53% | |
Senior Notes | ||
Debt Instrument [Line Items] | ||
Total debt | $ 20,966 | 22,945 |
Senior Notes | 2.80% Senior Notes due December 2022 | U.S. | ||
Debt Instrument [Line Items] | ||
Total debt | $ 0 | 2,250 |
Effective interest rate (percent) | 2.89% | |
Stated interest rate (percent) | 2.80% | |
Senior Notes | 3.15% Senior Notes due December 2025 | U.S. | ||
Debt Instrument [Line Items] | ||
Total debt | $ 4,000 | 4,000 |
Effective interest rate (percent) | 3.26% | |
Stated interest rate (percent) | 3.15% | |
Senior Notes | 1.90% Senior Notes due April 2027 | U.S. | ||
Debt Instrument [Line Items] | ||
Total debt | $ 1,500 | 1,500 |
Effective interest rate (percent) | 2.02% | |
Stated interest rate (percent) | 1.90% | |
Senior Notes | 0.75% Senior Notes due August 2027 | U.S. | ||
Debt Instrument [Line Items] | ||
Total debt | $ 500 | 500 |
Effective interest rate (percent) | 0.84% | |
Stated interest rate (percent) | 0.75% | |
Senior Notes | 2.75% Senior Notes due September 2027 | U.S. | ||
Debt Instrument [Line Items] | ||
Total debt | $ 750 | 750 |
Effective interest rate (percent) | 2.91% | |
Stated interest rate (percent) | 2.75% | |
Senior Notes | 2.05% Senior Notes due April 2030 | U.S. | ||
Debt Instrument [Line Items] | ||
Total debt | $ 1,500 | 1,500 |
Effective interest rate (percent) | 2.13% | |
Stated interest rate (percent) | 2.05% | |
Senior Notes | 1.10% Senior Notes due February 2031 | U.S. | ||
Debt Instrument [Line Items] | ||
Total debt | $ 1,000 | 1,000 |
Effective interest rate (percent) | 1.20% | |
Stated interest rate (percent) | 1.10% | |
Senior Notes | 4.15% Senior Notes due December 2035 | U.S. | ||
Debt Instrument [Line Items] | ||
Total debt | $ 1,500 | 1,500 |
Effective interest rate (percent) | 4.23% | |
Stated interest rate (percent) | 4.15% | |
Senior Notes | 2.70% Senior Notes due April 2040 | U.S. | ||
Debt Instrument [Line Items] | ||
Total debt | $ 1,000 | 1,000 |
Effective interest rate (percent) | 2.80% | |
Stated interest rate (percent) | 2.70% | |
Senior Notes | 4.30% Senior Notes due December 2045 | U.S. | ||
Debt Instrument [Line Items] | ||
Total debt | $ 3,500 | 3,500 |
Effective interest rate (percent) | 4.37% | |
Stated interest rate (percent) | 4.30% | |
Senior Notes | 3.65% Senior Notes due September 2047 | U.S. | ||
Debt Instrument [Line Items] | ||
Total debt | $ 750 | 750 |
Effective interest rate (percent) | 3.73% | |
Stated interest rate (percent) | 3.65% | |
Senior Notes | 2.00% Senior Notes due August 2050 | U.S. | ||
Debt Instrument [Line Items] | ||
Total debt | $ 1,750 | $ 1,750 |
Effective interest rate (percent) | 2.09% | |
Stated interest rate (percent) | 2% | |
Senior Notes | 1.50% Senior Notes due June 2026 | Europe | ||
Debt Instrument [Line Items] | ||
Stated interest rate (percent) | 1.50% | |
Senior Notes | 2.00% Senior Notes due June 2029 | Europe | ||
Debt Instrument [Line Items] | ||
Stated interest rate (percent) | 2% | |
Senior Notes | 2.375% Senior Notes due June 2034 | Europe | ||
Debt Instrument [Line Items] | ||
Stated interest rate (percent) | 2.375% |
Debt - Additional Information (
Debt - Additional Information (Details) $ in Millions, € in Billions | 3 Months Ended | ||
Dec. 31, 2022 USD ($) | Dec. 31, 2022 EUR (€) | Dec. 31, 2021 USD ($) | |
Debt Instrument [Line Items] | |||
Repayments senior notes | $ | $ 2,250 | $ 0 | |
Net Investment Hedging | |||
Debt Instrument [Line Items] | |||
Notional amount of non-derivative instruments | € | € 1.8 | ||
Senior Notes | Europe | |||
Debt Instrument [Line Items] | |||
Debt instrument, face amount | € | € 3 | ||
December 2022 Notes | Senior Notes | |||
Debt Instrument [Line Items] | |||
Repayments senior notes | $ | $ 2,250 |
Settlement Guarantee Manageme_3
Settlement Guarantee Management - Additional Information (Details) $ in Billions | 3 Months Ended |
Dec. 31, 2022 USD ($) | |
Settlement Guarantee Management [Abstract] | |
Maximum settlement exposure | $ 123.5 |
Average daily settlement exposure | $ 76 |
Settlement Guarantee Manageme_4
Settlement Guarantee Management - Collateral (Detail) - USD ($) $ in Millions | Dec. 31, 2022 | Sep. 30, 2022 |
Settlement Guarantee Management [Abstract] | ||
Restricted cash and restricted cash equivalents | $ 2,591 | $ 2,342 |
Pledged securities at market value | 255 | 213 |
Letters of credit | 1,659 | 1,582 |
Guarantees | 984 | 950 |
Total | $ 5,489 | $ 5,087 |
Stockholders' Equity - Number o
Stockholders' Equity - Number of Shares of Class A Common Shares Outstanding on an As-Converted Basis (Details) shares in Millions | Dec. 31, 2022 shares | Sep. 30, 2022 shares |
Schedule of Common Stock as Converted [Line Items] | ||
As-converted Class A Common Stock (in shares) | 2,087 | 2,103 |
Series A preferred stock | ||
Schedule of Common Stock as Converted [Line Items] | ||
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Preferred stock, conversion rate into Class A Common Stock | 100 | 100 |
As-converted Class A Common Stock (in shares) | 11 | 16 |
Series B preferred stock | ||
Schedule of Common Stock as Converted [Line Items] | ||
Preferred stock, shares outstanding (in shares) | 2 | 2 |
Preferred stock, conversion rate into Class A Common Stock | 2.9580 | 2.9710 |
As-converted Class A Common Stock (in shares) | 7 | 7 |
Series C preferred stock | ||
Schedule of Common Stock as Converted [Line Items] | ||
Preferred stock, shares outstanding (in shares) | 3 | 3 |
Preferred stock, conversion rate into Class A Common Stock | 3.6340 | 3.6450 |
As-converted Class A Common Stock (in shares) | 11 | 12 |
Class A common stock | ||
Schedule of Common Stock as Converted [Line Items] | ||
Common stock, shares outstanding (in shares) | 1,626 | 1,635 |
As-converted Class A Common Stock (in shares) | 1,626 | 1,635 |
Class B common stock | ||
Schedule of Common Stock as Converted [Line Items] | ||
Common stock, shares outstanding (in shares) | 245 | 245 |
Common stock, conversion rate into Class A Common Stock | 1.5991 | 1.6059 |
As-converted Class A Common Stock (in shares) | 393 | 394 |
Class C common stock | ||
Schedule of Common Stock as Converted [Line Items] | ||
Common stock, shares outstanding (in shares) | 10 | 10 |
Common stock, conversion rate into Class A Common Stock | 4 | 4 |
As-converted Class A Common Stock (in shares) | 39 | 39 |
Stockholders' Equity - Schedule
Stockholders' Equity - Schedule of As-Converted Class B Common Stock (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions | 3 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Stockholders' Equity Note [Abstract] | ||
Reduction in equivalent number of as-converted shares of class A common stock (in shares) | 2 | 1 |
Effective price per share (in dollars per share) | $ 209.14 | $ 217.61 |
Deposits under the U.S. retrospective responsibility plan | $ 350 | $ 250 |
Stockholders' Equity - Effect o
Stockholders' Equity - Effect of VE Territory Covered Losses Through Conversion Rate Adjustments (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions | 3 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Conversion of Stock [Line Items] | ||
Recovery through conversion rate adjustment | $ 1 | $ 0 |
Series B preferred stock | ||
Conversion of Stock [Line Items] | ||
Reduction in equivalent number of as-converted shares of class A common stock (in shares) | 0 | 0 |
Effective price per share (in dollars per share) | $ 211.34 | $ 201.68 |
Recovery through conversion rate adjustment | $ 7 | $ 26 |
Series C preferred stock | ||
Conversion of Stock [Line Items] | ||
Reduction in equivalent number of as-converted shares of class A common stock (in shares) | 0 | 0 |
Effective price per share (in dollars per share) | $ 211.34 | $ 201.68 |
Recovery through conversion rate adjustment | $ 7 | $ 3 |
Stockholders' Equity - Share Re
Stockholders' Equity - Share Repurchases in the Open Market (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions | 3 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Equity, Class of Treasury Stock [Line Items] | ||
Total cost | $ 3,115 | $ 4,104 |
Class A common stock | ||
Equity, Class of Treasury Stock [Line Items] | ||
Shares repurchased in the open market (in shares) | 16 | 19 |
Average repurchase price per share (in dollars per share) | $ 197.69 | $ 210.32 |
Total cost | $ 3,115 | $ 4,104 |
Stockholders' Equity - Addition
Stockholders' Equity - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | |||
Dec. 31, 2022 | Dec. 31, 2021 | Jan. 24, 2023 | Oct. 31, 2022 | |
Equity, Class of Treasury Stock [Line Items] | ||||
Share repurchase program | $ 12,000 | $ 12,000 | ||
Share repurchase programs authorized | $ 14,100 | |||
Dividends paid | $ 945 | $ 809 | ||
Subsequent Event | ||||
Equity, Class of Treasury Stock [Line Items] | ||||
Quarterly cash dividend (in dollars per share) | $ 0.45 |
Earnings Per Share - Basic and
Earnings Per Share - Basic and Diluted Earnings Per Share (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions | 3 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Line Items] | ||
Income Allocation - Basic | $ 4,179 | $ 3,959 |
Class A common stock | ||
Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Line Items] | ||
Income Allocation - Basic | $ 3,243 | $ 3,065 |
Weighted- Average Shares Outstanding - Basic (in shares) | 1,629 | 1,669 |
Earnings per Share - Basic (in dollars per share) | $ 1.99 | $ 1.84 |
Income Allocation - Diluted | $ 4,179 | $ 3,959 |
Weighted- Average Shares Outstanding - Diluted (in shares) | 2,102 | 2,159 |
Earnings per Share - Diluted (in dollars per share) | $ 1.99 | $ 1.83 |
Class B common stock | ||
Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Line Items] | ||
Income Allocation - Basic | $ 784 | $ 732 |
Weighted- Average Shares Outstanding - Basic (in shares) | 245 | 245 |
Earnings per Share - Basic (in dollars per share) | $ 3.19 | $ 2.98 |
Income Allocation - Diluted | $ 784 | $ 731 |
Weighted- Average Shares Outstanding - Diluted (in shares) | 245 | 245 |
Earnings per Share - Diluted (in dollars per share) | $ 3.19 | $ 2.98 |
Weighted-average as-converted common stock used in income allocation (in shares) | 394 | 398 |
Class C common stock | ||
Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Line Items] | ||
Income Allocation - Basic | $ 78 | $ 74 |
Weighted- Average Shares Outstanding - Basic (in shares) | 10 | 10 |
Earnings per Share - Basic (in dollars per share) | $ 7.96 | $ 7.35 |
Income Allocation - Diluted | $ 78 | $ 74 |
Weighted- Average Shares Outstanding - Diluted (in shares) | 10 | 10 |
Earnings per Share - Diluted (in dollars per share) | $ 7.95 | $ 7.34 |
Weighted-average as-converted common stock used in income allocation (in shares) | 39 | 40 |
Participating securities | ||
Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Line Items] | ||
Income Allocation - Basic | $ 74 | $ 88 |
Income Allocation - Diluted | $ 74 | $ 88 |
Series A preferred stock | ||
Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Line Items] | ||
Weighted-average as-converted common stock used in income allocation (in shares) | 13 | 7 |
Series B preferred stock | ||
Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Line Items] | ||
Weighted-average as-converted common stock used in income allocation (in shares) | 7 | 16 |
Series C preferred stock | ||
Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Line Items] | ||
Weighted-average as-converted common stock used in income allocation (in shares) | 11 | 22 |
Share-based Compensation - Awar
Share-based Compensation - Awards Granted to Company Employees and Non-employee Directors Under the 2007 Equity Incentive Compensation Plan (Details) | 3 Months Ended |
Dec. 31, 2022 $ / shares shares | |
Non-qualified stock options | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Granted (in shares) | shares | 785,254 |
Weighted-Average Grant Date Fair Value (in dollars per share) | $ 57.29 |
Weighted-Average Exercise Price (in dollars per share) | $ 210.80 |
Restricted stock units | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Granted (in shares) | shares | 2,998,777 |
Weighted-Average Grant Date Fair Value (in dollars per share) | $ 210.18 |
Performance-based shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Granted (in shares) | shares | 457,178 |
Weighted-Average Grant Date Fair Value (in dollars per share) | $ 216.08 |
Share-based Compensation - Addi
Share-based Compensation - Additional Information (Details) - USD ($) $ in Millions | 3 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
2007 Plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Share-based compensation cost | $ 170 | $ 121 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) $ in Millions | 3 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | ||
Effective income tax rate reconciliation, percent (in percent) | 16% | 19% |
Recognized tax benefit | $ 142 | |
Decrease in unrecognized tax benefits, gross | 108 | |
Decrease in unrecognized tax benefits, net | $ 149 |
Legal Matters - Schedule of Acc
Legal Matters - Schedule of Accrued Litigation for Both Covered and Non-Covered Litigation (Detail) - USD ($) $ in Millions | 3 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Loss Contingency Accrual [Roll Forward] | ||
Balance at beginning of period | $ 1,456 | $ 983 |
Balance at end of period | 1,702 | 1,027 |
Uncovered Litigation | ||
Loss Contingency Accrual [Roll Forward] | ||
Provision for legal matters | 0 | 1 |
Covered Litigation | ||
Loss Contingency Accrual [Roll Forward] | ||
Provision for legal matters | 347 | 146 |
Payments for legal matters | (101) | (103) |
U.S. Covered Litigation | ||
Loss Contingency Accrual [Roll Forward] | ||
Balance at beginning of period | 1,441 | 881 |
Provision for legal matters | 341 | 145 |
Payments for legal matters | (101) | 0 |
Balance at end of period | 1,681 | 1,026 |
VE Territory Covered Litigation | ||
Loss Contingency Accrual [Roll Forward] | ||
Balance at beginning of period | 11 | 102 |
Provision for legal matters | 6 | 1 |
Payments for legal matters | 0 | (102) |
Balance at end of period | $ 17 | $ 1 |
Legal Matters - Additional Info
Legal Matters - Additional Information (Details) $ in Millions | 3 Months Ended | 115 Months Ended | |
Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | Jan. 27, 2023 merchant | |
Loss Contingencies [Line Items] | |||
Deposits into the litigation escrow account | $ | $ 350 | $ 250 | |
U.S. Covered Litigation | |||
Loss Contingencies [Line Items] | |||
Provision for legal matters | $ | 341 | $ 145 | |
Deposits into the litigation escrow account | $ | $ 350 | ||
Interchange Multidistrict Litigation | |||
Loss Contingencies [Line Items] | |||
Settlement percentage | 62% | ||
Europe Merchant Litigation | Subsequent Event | |||
Loss Contingencies [Line Items] | |||
Number of plaintiffs | 900 | ||
Number of claims settled | 150 | ||
Number of claims pending | 700 | ||
Europe Merchant Litigation | Threatened Litigation | Subsequent Event | |||
Loss Contingencies [Line Items] | |||
Number of plaintiffs | 30 |